Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B
Autor: | Von Drygalski, Annette, Giermasz, Adam, Castaman, Giancarlo, Key, Nigel S., Lattimore, Susan, Leebeek, Frank W.G., Miesbach, Wolfgang, Recht, Michael, Long, Alison, Gut, Robert, Sawyer, Eileen K., Pipe, Steven W. |
---|---|
Zdroj: | In Blood Advances 12 November 2019 3(21):3241-3247 |
Databáze: | ScienceDirect |
Externí odkaz: |